Literature DB >> 19528214

Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii.

Kimberly A Jordan1, Emma H Wilson, Elia D Tait, Barbara A Fox, David S Roos, David J Bzik, Florence Dzierszinski, Christopher A Hunter.   

Abstract

Multiple studies have established that the ability of CD8(+) T cells to act as cytolytic effectors and produce gamma interferon is important in mediating resistance to the intracellular parasite Toxoplasma gondii. To better understand the generation of the antigen-specific CD8(+) T-cell responses induced by T. gondii, mice were immunized with replication-deficient parasites that express the model antigen ovalbumin (OVA). Class I tetramers specific for SIINFEKL were used to track the OVA-specific endogenous CD8(+) T cells. The peak CD8(+) T-cell response was found at day 10 postimmunization, after which the frequency and numbers of antigen-specific cells declined. Unexpectedly, replication-deficient parasites were found to induce antigen-specific cells with faster kinetics than replicating parasites. The generation of optimal numbers of antigen-specific CD8(+) effector T cells was found to require CD4(+) T-cell help. At 7 days following immunization, antigen-specific cells were found to be CD62L(low), KLRG1(+), and CD127(low), and they maintained this phenotype for more than 70 days. Antigen-specific CD8(+) effector T cells in immunized mice exhibited potent perforin-dependent OVA-specific cytolytic activity in vivo. Perforin-dependent cytolysis appeared to be the major cytolytic mechanism; however, a perforin-independent pathway that was not mediated via Fas-FasL was also detected. This study provides further insight into vaccine-induced cytotoxic T-lymphocyte responses that correlate with protective immunity to T. gondii and identifies a critical role for CD4(+) T cells in the generation of protective CD8(+) T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19528214      PMCID: PMC2738025          DOI: 10.1128/IAI.00024-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  CD8(+)-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4(+) T cells.

Authors:  Lori Casciotti; Kenneth H Ely; Martha E Williams; Imtiaz A Khan
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 2.  Development of a vaccine for toxoplasmosis: current status.

Authors:  Girish M Bhopale
Journal:  Microbes Infect       Date:  2003-04       Impact factor: 2.700

3.  Requirement for CD4 T cell help in generating functional CD8 T cell memory.

Authors:  Devon J Shedlock; Hao Shen
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

4.  Adaptive immunity and enhanced CD8+ T cell response to Listeria monocytogenes in the absence of perforin and IFN-gamma.

Authors:  V P Badovinac; J T Harty
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

5.  De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii.

Authors:  Barbara A Fox; David J Bzik
Journal:  Nature       Date:  2002-02-21       Impact factor: 49.962

6.  The induction and kinetics of antigen-specific CD8 T cells are defined by the stage specificity and compartmentalization of the antigen in murine toxoplasmosis.

Authors:  Lai-Yu Kwok; Sonja Lütjen; Sabine Soltek; Dominique Soldati; Dirk Busch; Martina Deckert; Dirk Schlüter
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

Review 7.  Cytotoxic T lymphocytes: all roads lead to death.

Authors:  Michele Barry; R Chris Bleackley
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

8.  A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection.

Authors:  T Scorza; S D'Souza; M Laloup; J Dewit; J De Braekeleer; H Verschueren; M Vercammen; K Huygen; E Jongert
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication.

Authors:  Jason P Gigley; Barbara A Fox; David J Bzik
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

10.  Defective CD8 T cell memory following acute infection without CD4 T cell help.

Authors:  Joseph C Sun; Michael J Bevan
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

View more
  36 in total

1.  Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival.

Authors:  Timothy W Hand; Weiguo Cui; Yong Woo Jung; Esen Sefik; Nikhil S Joshi; Anmol Chandele; Ying Liu; Susan M Kaech
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

2.  Role of the NF-κB transcription factor c-Rel in the generation of CD8+ T-cell responses to Toxoplasma gondii.

Authors:  Kimberly A Jordan; Christopher D Dupont; Elia D Tait; Hsiou-Chi Liou; Christopher A Hunter
Journal:  Int Immunol       Date:  2010-11       Impact factor: 4.823

Review 3.  Nucleic acid transfection and transgenesis in parasitic nematodes.

Authors:  James B Lok
Journal:  Parasitology       Date:  2011-08-31       Impact factor: 3.234

4.  Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells.

Authors:  Elia D Tait; Kimberly A Jordan; Christopher D Dupont; Tajie H Harris; Beth Gregg; Emma H Wilson; Marion Pepper; Florence Dzierszinski; David S Roos; Christopher A Hunter
Journal:  J Immunol       Date:  2010-06-30       Impact factor: 5.422

Review 5.  The CD8 T-cell road to immunotherapy of toxoplasmosis.

Authors:  Rajarshi Bhadra; Jason P Gigley; Imtiaz A Khan
Journal:  Immunotherapy       Date:  2011-06       Impact factor: 4.196

6.  The IL-12- and IL-23-Dependent NK Cell Response Is Essential for Protective Immunity against Secondary Toxoplasma gondii Infection.

Authors:  Daria L Ivanova; Tiffany M Mundhenke; Jason P Gigley
Journal:  J Immunol       Date:  2019-10-11       Impact factor: 5.422

7.  Role of CD4+ Foxp3+ Regulatory T Cells in Protection Induced by a Live Attenuated, Replicating Type I Vaccine Strain of Toxoplasma gondii.

Authors:  Haroon Akbar; Isabelle Dimier-Poisson; Nathalie Moiré
Journal:  Infect Immun       Date:  2015-06-29       Impact factor: 3.441

8.  Diverse roles for T-bet in the effector responses required for resistance to infection.

Authors:  Gretchen Harms Pritchard; Aisling O'Hara Hall; David A Christian; Sagie Wagage; Qun Fang; Gaia Muallem; Beena John; Arielle Glatman Zaretsky; William G Dunn; Jacqueline Perrigoue; Steven L Reiner; Christopher A Hunter
Journal:  J Immunol       Date:  2015-01-02       Impact factor: 5.422

9.  Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment.

Authors:  Jason R Baird; Barbara A Fox; Kiah L Sanders; Patrick H Lizotte; Juan R Cubillos-Ruiz; Uciane K Scarlett; Melanie R Rutkowski; Jose R Conejo-Garcia; Steven Fiering; David J Bzik
Journal:  Cancer Res       Date:  2013-05-23       Impact factor: 12.701

10.  Attenuated Toxoplasma gondii therapy of disseminated pancreatic cancer generates long-lasting immunity to pancreatic cancer.

Authors:  Kiah L Sanders; Barbara A Fox; David J Bzik
Journal:  Oncoimmunology       Date:  2015-10-29       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.